Genomic Health

Health genetics medical diagnostics oncology

Genomic Health, Inc. is the provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The Company is applying its scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring.

Company Growth (employees)

Type

Public

Redwood City, US

Founded

2000

Size (employees)

846 (est)+6%

Website

genomichealth.com

Genomic Health was founded in 2000 and is headquartered in Redwood City, US

Genomic Health Office Locations

Genomic Health has an office in Redwood City

Redwood City, US (HQ)

301 Penobscot Dr

Genomic Health Data and Metrics

Genomic Health Financial Metrics

Genomic Health's revenue was reported to be $327.9 m in FY, 2016 which is a 14% increase from the previous period.

Summary

USD

Genomic Health's current market capitalization is $1.1 b.

Income Statement

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Revenue	261.6 m	275.7 m	287.5 m	327.9 m
Revenue growth, %		5%	4%	14%
Operating expense total	231.3 m	250.6 m	267.7 m	343.3 m
EBIT	(11.8 m)	(23.6 m)	(34 m)	(15.4 m)
EBIT margin, %	(5%)	(9%)	(12%)	(5%)
Interest income	222 k	192 k	221 k	418 k
Pre tax profit	(12.4 m)	(24.2 m)	(34.3 m)	(12.5 m)
Income tax expense	346 k	393 k	(996 k)	1.4 m
Net Income	(12.8 m)	(24.6 m)	(33.3 m)	(13.9 m)

Balance Sheet

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	33.3 m	29.7 m	32.5 m	40.4 m
Accounts Receivable	29.4 m	34.9 m	37.2 m	35.2 m
Inventories	10.2 m	9.9 m	10.8 m	13.8 m
Current Assets	145 m	148.5 m	143 m	146 m
PP&E	18.3 m	21.9 m	39.7 m	45.7 m
Total Assets	177 m	185.9 m	184.6 m	201.1 m
Accounts Payable	5.2 m	7 m	8.6 m	2.9 m
Current Liabilities	29.8 m	38.3 m	42.7 m	41.2 m
Additional Paid-in Capital	345.3 m	370.5 m
Retained Earnings	(170.3 m)	(194.9 m)	(228.2 m)	(242.1 m)
Total Equity	145 m	145.5 m	139.5 m	156.1 m
Financial Leverage	1.2 x	1.3 x	1.3 x	1.3 x

Cash Flow

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	(12.8 m)	(24.6 m)	(33.3 m)	(13.9 m)
Depreciation and Amortization	6.3 m		7.1 m	8.9 m
Accounts Receivable	(7.2 m)	34.9 m	(2.2 m)	2 m
Inventories		9.9 m
Accounts Payable	1.2 m	7 m	949 k	(4.6 m)
Cash From Operating Activities	8.6 m	(3.6 m)	(11.8 m)	13.5 m
Purchases of PP&E	(11 m)		(23.5 m)	(19.8 m)
Cash From Investing Activities	(7 m)		6.3 m	(19.1 m)
Cash From Financing Activities	13.7 m		8.4 m	13.5 m
Income Taxes Paid	336 k		459 k	428 k